Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Drug Discovery Today|December 3, 2014
Emerging therapeutic strategies in COPDKesavan S Babu, Jaymin B MorjariaExpert Opinion on Investigational Drugs|January 25, 2017
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary diseaseMario Malerba, Alessandro Radaeli, Paolo Montuschi, et al.Journal of Asthma and Allergy|March 26, 2011
Recommendation for optimal management of severe refractory asthmaJaymin B Morjaria, Riccardo PolosaExpert Review of Respiratory Medicine|May 19, 2010
Off-label use of omalizumab in non-asthma conditions: new opportunitiesJaymin B Morjaria, Riccardo PolosaTherapeutic Advances in Chronic Disease|December 20, 2012
Unusual asthma syndromes and their managementJaymin B Morjaria, Jack A KastelikTherapeutic Advances in Respiratory Disease|March 11, 2015
Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary diseaseK Suresh Babu, Jaymin B MorjariaDrug Discovery Today|March 13, 2010
Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPDJaymin B Morjaria, Mario Malerba, Riccardo PolosaDrug Discovery Today|November 29, 2011
Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspectsMario Malerba, Alessandro Radaeli, Jaymin B MorjariaCurrent Opinion in Allergy and Clinical Immunology|December 15, 2010
Stratified medicine in selecting biologics for the treatment of severe asthmaJaymin B Morjaria, Maria Proiti, Riccardo PolosaLung|March 4, 2017
Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT StudyJaymin B Morjaria, Alan Rigby, Alyn H MoricePageof 6